PainCareLive

CME Presentations

Opioid Use Disorder


Presentations


Speakers

  • Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Peter D. Friedmann, MD, MPH, DFASAM, FACP

    Associate Dean for Research and Professor of Medicine

    Peter D. Friedmann, MD, MPH, DFASAM, FACP, is a primary care internist, addiction medicine clinician, and established substance abuse researcher who has published over 145 peer-reviewed articles on the organization of treatment services, treatment process and outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction and correctional settings and the role of the physicians in the care of patients with SUDs. He is the chief research officer at Baystate Health, associate dean for research and professor of medicine at University of Massachusetts Medical School-Baystate, and professor of quantitative health sciences, University of Massachusetts Medical School. He received his medical degree from Boston University School of Medicine.
  • Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Genie L. Bailey, MD, DABAM

    Clinical Associate Professor of Psychiatry and Human Behavior

    Genie L. Bailey, MD, DABAM, is associate clinical professor of psychiatry and human behavior at Alpert Medical School, Brown University in Providence, Rhode Island, and is director of research and director of the Medication for Addiction Treatment (MAT) program at Stanley Street Treatment and Resources (SSTAR) in Fall River, Massachusetts. Dr Bailey was the site principal investigator (PI) for 3, multicenter randomized controlled trials funded through NIDA’s Clinical Trials Network, and a consortium PI on a project funded by NIH/NIDA to evaluate an implantable treatment for opioid dependency. She received her medical degree from Duke Medical School in Durham, North Carolina.
  • Joji Suzuki, MD

    Joji Suzuki, MD

    Joji Suzuki, MD

    Assistant Professor of Psychiatry

    Joji Suzuki, MD, is the director of the Division of Addiction Psychiatry and director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an assistant professor of psychiatry at Harvard Medical School in Boston, Massachusetts. He is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital, and the site director for the Addiction Psychiatry Fellowships for Partners HealthCare and Boston University School of Medicine. Dr Suzuki’s research focuses on integrating evidence-based addiction treatment initiated in general medical setting. He has published over 50 peer-reviewed manuscripts and book chapters as first or co-author. Dr Suzuki received his medical degree from Boston University School of Medicine.

CME Information

Taming the Beast: Management of Opioid Use Disorder in Hospital and Outpatient/Community Settings


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Adopt an evidence-based, medication-assisted treatment plan for appropriate patients with opioid use disorder
  • Address barriers to treatment nonadherence in patients with opioid use disorders
  • Summarize qualifications required for a physician waiver to prescribe and dispense buprenorphine under the Drug Addiction Treatment Act of 2000

Acknowledgement

This activity is supported by an educational grant from Indivior Inc.

Tuition

Complimentary

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity

Friday, May 4, 2018 from 12:00pm – 1:30pm EDT

Enduring Material

The enduring material will be available from May 4, 2018 to May 4, 2019

Target Audience

This activity is intended for emergency medicine physicians, hospitalists, primary care physicians, internal medicine physicians, psychiatrists, advanced practice providers, nurses, pharmacists, and health care providers (HCPs) involved in the care of patients with OUD.

Estimated Time to Complete

This activity consists of two sessions which should take approximately 1.5 hour to complete

Method Of Participation

There are no fees to participate in this activity. To participate in the activity, go to www.PsychiatryCareLive.com or www.PainCareLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Facutly

Genie L. Bailey, MD, DABAM
Clinical Associate Professor of Psychiatry and Human Behavior
Warren Alpert Medical School, Brown University
Director of Research, Director of Medications for Addiction Treatment Program
Stanley Street Treatment and Resources

Peter D. Friedmann, MD, MPH, DFASAM, FACP
Associate Dean for Research and Professor of Medicine
University of Massachusetts-Baystate
Chief Research Officer and Endowed Chair for Clinical Research
Baystate Health
Professor of Quantitative Health Sciences
University of Massachusetts Medical School

Joji Suzuki, MD
Director, Division of Addiction Psychiatry
Director of Addictions Education
Department of Psychiatry, Brigham and Women's Hospital
Assistant Professor of Psychiatry
Harvard Medical School

Disclosure of Conflict of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Genie L. Bailey, MD
Consulting Fees: Alkermes, Braeburn Pharmaceuticals
Speakers' Bureau: Alkermes, BioDelivery Sciences Inc., Indivior
Contracted Research: Braeburn Pharmaceuticals, Indivior
Other (travel expenses): Alkermes, Braeburn Pharmaceuticals, Indivior

Peter D. Friedmann, MD, MPH, DFASAM
Consulting Fees: Endo Pharmaceuticals

Joji Suzuki, MD
None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Anne Roc, PhD, None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support
For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive or PainCareLive at 877-394-1306 or at Support@PsychiatryCareLive.com. or Support@PainCareLive.com..